Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Yu, FL

Alex Yu, Safety Harbor, FL US

Patent application numberDescriptionPublished
20110106003DIALYSIS SYSTEM AND METHOD FOR CASSETTE-BASED PUMPING AND VALVING - A peritoneal dialysis system includes a disposable cassette including a flexible sheet; a hardware unit including (i) at least one pump actuator and piston head moved by the pump actuator, (ii) at least one valve actuator, (iii) at least one sensor, and (iv) a disposable cassette interface for interfacing with the disposable cassette, the disposable cassette interface including: (a) at least one pump aperture, the at least one piston head moveable out of and retractable into the at least one pump aperture to move a corresponding pumping portion of the flexible sheet of the disposable cassette, the piston head moving within a vacuum chamber, the vacuum chamber enabling a vacuum to be pulled around the piston head to the flexible sheet of the disposable cassette; (b) at least one valve aperture, at least a portion of the at least one valve actuator located in the valve aperture to move a valve portion of the flexible sheet of the disposable cassette; and (c) at least one sensor aperture, the at least one sensor located in the at least one sensor aperture, the at least one sensor operable with a sensor portion of the flexible sheet of the disposable cassette.05-05-2011

Alex Anping Yu, Safety Harbor, FL US

Patent application numberDescriptionPublished
20100087777PERITONEAL DIALYSIS MACHINE WITH VARIABLE VOLTAGE INPUT CONTROL SCHEME - A dialysis machine includes: (i) a source of peritoneal dialysis solution; (ii) a patient line for passing the peritoneal dialysis solution to the peritoneal cavity of a patient; (iii) a pump for pumping the peritoneal dialysis solution to the peritoneal cavity via the patient line; (iv) a heater for heating the peritoneal dialysis solution prior to the dialysis solution reaching the patient line, the heater including first and second heating elements; (v) a voltage input from a remote power source; and (vi) a control scheme responsive to the voltage input and configured to (a) automatically maintain a proper dialysis solution temperature for the patient via the first and second heating elements regardless of the voltage input wherein the control (b) account for an inlet temperature of the dialysis solution to the heater and (c) account for heater efficiency.04-08-2010

Anping Yu, Safety Harbor, FL US

Patent application numberDescriptionPublished
20100010423DIALYSIS SYSTEM HAVING FILTERING METHOD FOR DETERMINING THERAPY PRESCRIPTIONS - A peritoneal dialysis system includes a logic implementer configured to: (i) generate a number of peritoneal dialysis therapy regimens that meet at least one therapy target input; (ii) accept a filter input; and (iii) filter the generated therapy regimens according to the filter input to refine the number of therapy regimens available for selection.01-14-2010
20100010424DIALYSIS SYSTEM HAVING REGIMEN GENERATION METHODOLOGY - A peritoneal dialysis system includes a logic implementer configured to: (i) accept at least one therapy target input; (ii) accept at least one patient transport characteristic input; (iii) accept at least one solution input; (iv) accept at least one fluid volume input; (v) accept at least one therapy time input, at least one of the inputs (ii) to (v) including an input range; and (vi) generate each therapy regimen using the inputs of (ii), (iii), (iv) and (v), including each of the possibilities within the at least one input range, that satisfy the at least one therapy target input.01-14-2010
20100010425PERITONEAL EQUILIBRATION TEST AND DIALYSIS SYSTEM USING SAME - An ultrafiltration (“UF”) evaluation method includes: (i) determining an amount of UF removed from a patient over a first dwell time; (ii) determine an amount of UF removed from the patient over a second, different dwell time; (iii) determining an amount of UF removed from the patient over a third, different dwell time; and (iv) fitting a curve to the UF removal amounts for the first, second and third dwell time. A peritoneal dialysis therapy generation method using the curve determined according to the “UF” evaluation method to generate at least one peritoneal dialysis therapy regimen.01-14-2010
20100010426DIALYSIS SYSTEM HAVING INVENTORY MANAGEMENT INCLUDING ONLINE DEXTROSE MIXING - A peritoneal dialysis system includes: a plurality of automated peritoneal dialysis (“APD”) machines; and a server computer in communication with the APD machines, the APD machines programmed to inform the server computer of how much dialysate is consumed over a first delivery period, the server computer configured to use the amounts consumed to determine dialysate delivery amounts for the plurality of APD machines for a second delivery period.01-14-2010
20100010427DIALYSIS SYSTEM HAVING TRENDING AND ALERT GENERATION - A peritoneal dialysis system includes: an automated peritoneal dialysis (“APD”) machine configured to remove ultrafiltrate (“UF”) from a patient and record how much UF has been removed; and a logic implementer configured to (i) form a first moving average UF removed trend, (ii) determine a trending range around the first moving average UF removed trend, (iii) determine at least one of an upper and lower UF removed limit from the trending range, (iv) form a second moving average UF removed trend, and (v) alert if the second moving average UF removed trend moves outside of the at least one UF removed limit.01-14-2010
20100010428DIALYSIS SYSTEM AND MACHINE HAVING THERAPY PRESCRIPTION RECALL - In one embodiment an automated peritoneal dialysis (“APD”) machine includes: at least one pump; a logic implementer storing a plurality of therapy prescriptions by which to operate the at least one pump, each therapy prescription pre-approved for a particular patient; and an input device operating with the logic implementer to allow the patient to select one of the therapy prescriptions for a particular therapy. In another embodiment, the input device operating with the logic implementer allows a doctor/clinician to select or approve one of the therapy prescriptions to be run on the APD machine. In a further embodiment, the logic implementer is programmed to select or suggest one of the therapy prescriptions to be run on the is APD machine.01-14-2010
20100298662SYSTEM AND METHOD FOR AUTOMATED DATA COLLECTION OF TWENTY-FOUR HOUR ULTRAFILTRATION AND OTHER PATIENT PARAMETERS USING WIRED OR WIRELESS TECHNOLOGY - A dialysis system includes: a dialysis machine for performing a first dialysis session on a patient at a first time of a day; a remote exchange device for performing a second dialysis session on the patient at a second time of the day, the remote exchange device configured to record an amount of ultrafiltration (“UF”) that is removed from the patient over the second dialysis session; and a communication link between the dialysis machine and the remote exchange device, wherein the dialysis machine is configured to receive the recorded amount UF removed from the remote exchange device via the communication link and determine a total amount of UF removed from the patient over the first and second sessions.11-25-2010

Bazhang Yu, Tampa, FL US

Patent application numberDescriptionPublished
20080206829EPOXY ENHANCED POLYMER MEMBRANE TO INCREASE DURABILITY OF BIOSENSORS - The present invention provides a polymer membrane enhanced with cured epoxy resin for use as the outer membrane of biosensors. The membrane includes approximately 30-80% epoxy resin adhesives, 10-60% polymer such as poly(vinyl chloride), polycarbonate and polyurethane and 0-30% plasticizers and 5-15% surface modifier reagent such as polyethylene oxide-containing block copolymers. Utilizing the polymer membrane of the present invention, a three-layered sensing element has been developed. This sensing element will be particularly useful for miniaturized biosensors used for in vitro blood measurements or for continuous in vivo monitoring such as implantable biosensors. This element includes an enzyme layer, an interference-eliminating layer and the novel polymer member of the present invention as the outer polymer layer. This novel sensing element shows excellent response characteristics in solutions and has an extremely long lifetime. This technology is particularly useful for improving the lifetime of implantable biosensors.08-28-2008

Chuanzhao Yu, Boynton Beach, FL US

Patent application numberDescriptionPublished
20090264090DC OFFSET CALIBRATION IN A DIRECT CONVERSION RECEIVER - A direct conversion receiver (10-22-2009

Howard Yu, Sunrise, FL US

Patent application numberDescriptionPublished
20100237631Oscillating Power Generator - An electrical power generating apparatus utilizes an oscillating assembly to power at least one generator. The oscillating assembly comprises an off-balanced wheel assembly having either a partially circumferential wheel ring or a circular wheel ring with an off-balanced weight distribution, assembled to a centrally located wheel hub. The pendulum assembly is pivotally assembled to a frame via the wheel hub. A counterbalancing beam extends upwardly from the wheel hub, bisecting the wheel, placing equal mass to each side, such that the pendulum assembly is symmetric. Weights can be disposed upon each of the counterbalancing beam and the wheel assembly to aid in optimizing the teetering operation of the oscillating assembly. As the oscillating assembly operates, the motion is transferred to the at least generator which creates an electrical power output. An actuator injects energy into the oscillating motion to overcome any losses due to friction, air resistance, and such.09-23-2010

Hua Yu, Tampa, FL US

Patent application numberDescriptionPublished
20100297061STAT3 ANTAGONISTS AND THEIR USES AS VACCINES AGAINST CANCER - The present invention relates to methods for treating and/or preventing cancer. In particular the present invention relates to ex vivo immunotherapeutic methods. The methods comprise decreasing Stat3 (signal transducer and activator of transcirption3) expression and/or function in tumor cells and the administration of such cells to a subject in need of treatment and/or prevention. Other methods of the invention comprise activation T-cells by co-culturing the T-cells with the tumor cells with decreased Stat3 expression or function. The invention further encompasses methods comprising decreasing Stat3 expression or function in antigen-presenting cells and co-administering tumor cells and the antigen-presenting cells with decreased Stat3 function to a patient. The invention further relates to methods for stimulating dendritic cell differentiation.11-25-2010
20100310645METHODS FOR INHIBITING TUMOR CELL PROLIFERATION - The subject invention concerns methods for inhibition of STAT biological functions using platinum complexes.12-09-2010

Patent applications by Hua Yu, Tampa, FL US